Nanobiotix (NASDAQ:NBTX) Shares Up 5.9% – Here’s What Happened

Nanobiotix S.A. – Sponsored ADR (NASDAQ:NBTX) shares rose 5.9% on Monday. The company traded as high as $31.18 and last traded at $31.1060. Approximately 5,710 shares were traded during trading, a decline of 94% from the average session volume of 94,543 shares. The stock had previously closed at $29.36.

Analysts Set New Price Targets

Several research analysts recently weighed in on NBTX shares. Guggenheim initiated coverage on shares of Nanobiotix in a report on Tuesday, September 15th. They set a “buy” rating and a $64.00 price target on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of Nanobiotix in a research note on Thursday, October 15th. Four equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Nanobiotix has an average rating of “Moderate Buy” and an average price target of $46.67.

Nanobiotix Trading Up 7.6%

The stock has a fifty day moving average of $33.44 and a 200 day moving average of $36.44.

Nanobiotix Company Profile

Nanobiotix is a biotechnology company developing nanoparticle-based therapies designed to improve the effectiveness of radiotherapy in cancer treatment. The company’s technology uses hafnium oxide nanoparticles that are injected directly into a tumor and activated by ionizing radiation, with the goal of increasing energy deposition within cancer cells while limiting exposure to surrounding tissue.

Nanobiotix’s lead product candidate, NBTXR3, is being evaluated in clinical studies across several cancer types, including locally advanced head and neck cancer and other solid tumors.